SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease
0 references·2 citing·8 second hop
Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease (2018)Cost Utility of Voretigene Neparvovec for…Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions (2020)Market access of gene therapi…A systematic review of economic evaluations of advanced therapy medicinal products (2020)A systematic review of econom…The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Value-based pricing for advanced therapy medicinal products: emerging affordability solutions (2021)Real World Data in Health Technology Assessment of Complex Health Technologies (2022)Advanced therapy medicinal products: current and future perspectives (2016)Overcoming Challenges Facing Advanced Therapies in the EU Market (2016)Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] (2018)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2020A systematic review of economic evaluations of advanced therapy medicinal products57 cited
  • 2020Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions53 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work